• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[甲状腺癌放射性碘治疗中造血系统的剂量学]

[Dosimetry of the hematopoietic system in radioiodine therapy of thyroid cancer].

作者信息

Günter H H, Junker D, Schober O, Hundeshagen H

出版信息

Strahlenther Onkol. 1987 Mar;163(3):185-91.

PMID:3563879
Abstract

Twenty patients were submitted to thyroidectomy and treated with iodine-131. Ten out of them received 100 mCi, the other ten 200 mCi. The activity of the total body and of the blood was determined by experimental proceeding. The doses absorbed by blood and bone marrow were calculated on the basis of the experimentally determined values. For the exposure of the blood, a medium value of 0.44 rd/mCi was found after 100 mCi and a medium value of 0.47 rd/mCi after 200 mCi. The corresponding values for the bone marrow are 0.24 and 0.3 rd/mCi, respectively. The total exposure is thus not so high as has been indicated hitherto in literature.

摘要

20名患者接受了甲状腺切除术并接受了碘-131治疗。其中10人接受了100毫居里,另外10人接受了200毫居里。通过实验方法测定了全身和血液的放射性。根据实验测定值计算血液和骨髓吸收的剂量。对于血液照射,100毫居里后发现的平均值为0.44拉德/毫居里,200毫居里后为0.47拉德/毫居里。骨髓的相应值分别为0.24和0.3拉德/毫居里。因此,总的照射量不像迄今文献中所指出的那么高。

相似文献

1
[Dosimetry of the hematopoietic system in radioiodine therapy of thyroid cancer].[甲状腺癌放射性碘治疗中造血系统的剂量学]
Strahlenther Onkol. 1987 Mar;163(3):185-91.
2
[Effectiveness of high-dosage radioiodine therapy in the elimination of remnant tissue following total thyroidectomy].[高剂量放射性碘治疗在全甲状腺切除术后残余组织清除中的有效性]
Nuklearmedizin. 1984 Oct;23(5):265-9.
3
Complications, sequela and dosimetry of iodine-131 therapy for thyroid carcinoma.甲状腺癌碘-131治疗的并发症、后遗症及剂量学
J Nucl Med. 1992 Dec;33(12):2214-21.
4
Empiric radioactive iodine dosing regimens frequently exceed maximum tolerated activity levels in elderly patients with thyroid cancer.经验性放射性碘给药方案常常超过老年甲状腺癌患者的最大耐受活性水平。
J Nucl Med. 2006 Oct;47(10):1587-91.
5
An analysis of "ablation of thyroid remnants" with I-131 in 511 patients from 1947-1984: experience at University of Michigan.1947年至1984年间对密歇根大学511例患者进行的I-131“甲状腺残余组织消融”分析:经验总结
J Nucl Med. 1984 Dec;25(12):1287-93.
6
Cumulative doses of adjunct 131I treatment depend on location of residual thyroid tissue after total thyroidectomy in differentiated thyroid cancer.分化型甲状腺癌全甲状腺切除术后辅助性¹³¹I治疗的累积剂量取决于残余甲状腺组织的位置。
J Pediatr Surg. 2007 May;42(5):853-6. doi: 10.1016/j.jpedsurg.2006.12.039.
7
Absence of bone marrow toxicity in elderly patients treated with recombinant human thyroid-stimulating hormone and empirically dosed radioiodine for thyroid cancer.重组人促甲状腺激素联合经验性碘-131 治疗甲状腺癌的老年患者无骨髓毒性。
Am J Clin Oncol. 2013 Aug;36(4):348-53. doi: 10.1097/COC.0b013e318248d67c.
8
Dosimetry-guided radioactive iodine treatment in patients with metastatic differentiated thyroid cancer: largest safe dose using a risk-adapted approach.剂量测定引导下的放射性碘治疗转移性分化型甲状腺癌患者:采用风险适应性方法的最大安全剂量
J Nucl Med. 2003 Mar;44(3):451-6.
9
A prospective clinical trial to assess the efficacy of radioiodine ablation as an alternative to completion thyroidectomy in patients with differentiated thyroid cancer undergoing sub-total thyroidectomy.一项前瞻性临床试验,旨在评估放射性碘消融作为接受甲状腺次全切除术的分化型甲状腺癌患者甲状腺全切术替代方案的疗效。
Acta Oncol. 2006;45(8):1067-72. doi: 10.1080/02841860500418377.
10
[Changes in the blood picture after radioiodine therapy of thyroid cancer].
Med Klin (Munich). 1994 Oct 15;89(10):522-8.